ScienceDex / Researcher record
Mohs, Richard Charles
- Agenebio, Inc. (no department on record)
From the FY2022 NIH awards this investigator leads as contact PI. The department is the award's.
- Sustained Excellence
- R01 Holder
- Early Career
NIH Funding · FY2022
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2017 | $4,000,000 | 1 | #765 |
| 2018 | $4,951,060 | 1 | #558 |
| 2019 | $4,948,571 | 1 | #656 |
| 2020 | $4,942,354 | 1 | #178 |
| 2021 | $2,844,834 | 1 | #1,876 |
| 2022 | $1,595,216 | 1 | #5,103 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY20171 record
- FY20181 record
- FY20191 record
- FY20201 record
- FY20211 record
- FY2022 · selected1 record
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2017 through FY2022Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2022 award records by amount
NIH award records listing Mohs, Richard Charles as a PI. Multi-PI records show the full award amount for context.
- 3R01AG061091-04S1R01Contact PIA Phase 3 Pivotal Trial of AGB101 to Slow Progression in MCI due to Alzheimer's Disease$1.6Maward amount
Award organization
Organizations that administered FY2022 awards listing Mohs, Richard Charles as a PI.
FY2022 award administered by Agenebio, Inc. (MD).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2017First NIH AwardAgenebio, Inc.
- 2017$500K Cumulative Funding
- 2017$1M Cumulative Funding
- 2017$2M Cumulative Funding
- 2017Entered Top 50% NationallyRanked #765
- 2017Entered Top 25% NationallyRanked #765
- 2017Entered Top 10% NationallyRanked #765
- 2017Entered Top 5% NationallyRanked #765
- 2018$5M Cumulative Funding
- 2019$10M Cumulative Funding
- 2019R01 Grant Holder
- 2020Entered Top 1% NationallyRanked #178